Abstract:In the healthy brain, astrocytes play vital roles essential for neuronal transmission and blood–brain barrier (BBB) integrity. The transformation of astrocytes into reactive states constitutes a biological response of the central nervous system (CNS) to insults and changes in brain environment. It is well known that astrocytes can replicate and accumulate prions independently of neurons [1–5]. However, considerably less is known about the impact of their reactive transformation on neuronal function and neurodegeneration. In prion diseases, the beneficial role of reactive astrocytes appears to be linked to astrocyte-produced milk fat globule epidermal growth factor 8 (Mfge8), which facilitates the engulfment of apoptotic bodies and the clearance of cellular debris [6]. However, alongside the enhancement of protective functions, it is crucial to weigh potential deficits in homeostatic roles and the emergence of detrimental functions when evaluating the overall impact of reactive astrocytes on disease progression. Recent studies suggested that reactive astrocytes may exert a net negative impact on both neurons and endothelial cells. Reactive astrocytes isolated from prion-infected animals exhibit detrimental effects on primary neurons causing reduction in dendritic spine size and density along with impairment of synapse integrity [7] (Fig 1). The synaptotoxic effects were mediated by changes in the astrocytic secretome, highlighting the potential role of altered signaling pathways in neuronal dysfunction. In addition to their effects on neurons, reactive astrocytes disrupt the integrity of the BBB. Coculturing experiments involving astrocytes from prion-infected animals or exposure to conditioned media from reactive astrocytes induced a disease-associated phenotype in endothelial cells isolated from normal mice [8] (Fig 1). This phenotype was characterized by the down-regulation and aberrant localization of tight and adherens junction proteins, and an increase in permeability of endothelial layers. Notably, a very strong reverse correlation was observed between the degree of astrocyte activation and the incubation time to the prion diseases [9]. Animal groups with rapid disease progression exhibit more severe astrocyte reactivity, suggesting a potential link between phenotypic changes in astrocytes and disease severity. This observation brings up the possibility that phenotypic changes in reactive astrocytes contribute to the faster disease progression. Consistent with this hypothesis, inhibition of the unfolded protein response, which is exacerbated in reactive astrocytes, via selective targeting of PERK signaling, was found to prolong the incubation time to terminal disease in mice [10]. In summary, reactive astrocytes associated with prion diseases exhibit harmful effects on neurons and endothelial cells and are likely contributors to disease progression. Further elucidation of the underlying mechanisms driving astrocyte reactivity may hold therapeutic potential for mitigating neurodegenerative processes associated with prion diseases.

The degree of astrocyte activation is predictive of the incubation time to prion disease

Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease.

Reactive astrocytes in prion diseases: Friend or foe?

Region-specific glial homeostatic signature in prion diseases is replaced by a uniform neuroinflammation signature, common for brain regions and prion strains with different cell tropism

Reactive astrocytes associated with prion disease impair the blood brain barrier

Complement 3+-astrocytes are highly abundant in prion diseases, but their abolishment led to an accelerated disease course and early dysregulation of microglia

RNA-seq and network analysis reveal unique glial gene expression signatures during prion infection

Abnormally Upregulated Αb-Crystallin Was Highly Coincidental with the Astrogliosis in the Brains of Scrapie-Infected Hamsters and Human Patients with Prion Diseases

Activation of Innate Immunity and Autophagy in Brain Tissues with Prion Disease and Degradation of Abnormal PrPs in Cells — China’s Studies

Neuroinflammation, Microglia, and Cell-Association during Prion Disease

Microglia-specific NF-κB signaling is a critical regulator of prion-induced glial inflammation and neuronal loss

The cell type resolved mouse transcriptome in neuron-enriched brain tissues from the hippocampus and cerebellum during prion disease

Early Activation of Astrocytes Does Not Affect Amyloid Plaque Load in an Animal Model of Alzheimer’s Disease

The Difference in Gliosis Induced by Β-Amyloid and Tau Treatments in Astrocyte Cultures Derived from Senescence Accelerated and Normal Mouse Strains

Cell adhesion molecule CD44 is dispensable for reactive astrocyte activation during prion disease

Novel Morphological Glial Alterations in the Spectrum of Prion Disease Types: A Focus on Common Findings

Diminished Neuronal ESCRT-0 Function Exacerbates AMPA Receptor Derangement and Accelerates Prion-Induced Neurodegeneration

Longitudinal progression of blood biomarkers reveals a key role of astrocyte reactivity in preclinical Alzheimer’s disease

Innate Immune Tolerance in Microglia Does Not Impact on Central Nervous System Prion Disease

Prions activate a p38 MAPK synaptotoxic signaling pathway

Morphofunctional Investigation in a Transgenic Mouse Model of Alzheimer's Disease: Non-Reactive Astrocytes Are Involved in Aβ Load and Reactive Astrocytes in Plaque Build-Up